Related Experiment Videos
[Monogenic hypertension]
Beata Łacka1, Maciej Tomaszewski, Ewa Zukowska-Szczechowska
1Katedra i Klinika Chorób Wewnetrznych, Diabetologii i Nefrologii w Zabrzu Slaskiej Akademii Medycznej w Katowicach. kchwdiab@infomed.slam.pl
Przeglad Lekarski
|April 3, 2004
Summary
Genetic factors significantly contribute to hypertension (HT). Studying rare single-gene mutations offers crucial insights into common hypertension forms like essential hypertension.
Area of Science:
- Genetics and Molecular Biology
- Cardiovascular Research
- Endocrinology
Context:
- Hypertension (HT) is a widespread condition with complex etiology.
- Genetic factors are increasingly recognized as significant contributors to HT development.
- Monogenic forms of HT, though rare, provide valuable models for understanding blood pressure regulation.
Purpose:
- To review the current understanding of monogenic hypertension syndromes.
- To highlight the genetic basis of hypertension and its implications for common forms of the disease.
- To catalog known monogenic forms of HT and their associated genetic mutations.
Summary:
- Numerous studies indicate a strong genetic influence on hypertension (HT) in both animals and humans.
- While syndromes caused by single-gene mutations leading to significant blood pressure changes are uncommon, their study is crucial.
- At least nine distinct monogenic forms of HT have been identified, including Liddle syndrome, familial hyperaldosteronism (GRA and type II), Gordon syndrome, apparent mineralocorticoid excess syndrome (AME), and specific congenital adrenal hyperplasia (CAH) types.
Impact:
- Understanding monogenic HT can illuminate the pathophysiology of essential hypertension.
- Insights from these rare syndromes may lead to novel therapeutic targets for common hypertension.
- This knowledge advances the field of cardiovascular genetics and personalized medicine.